Xcell Biosciences and Culture Biosciences have entered a collaboration to integrate Culture’s cloud‑native AI and machine‑learning platform with Xcell’s AVATAR™ Foundry system – a cGMP‑grade manufacturing platform for cell and gene therapies. Through this integration, scientists using AVATAR will gain remote visibility into critical cell‑culture parameters – such as temperature, oxygen and pH – across multiple systems, enabling real‑time monitoring and multivariate data analysis of cell‑therapy performance.
Also Read: NextEra Energy and Google Cloud Forge Major AI-Energy Partnership to Power Gigawatt-Scale Data Centers
This data-driven approach lets developers change metabolic conditions, growth times, and nutrient inputs. They adjust these factors based on each patient’s biology. This move goes beyond one-size-fits-all methods. The partnership provides a more customized, predictable, and repeatable approach. This boosts the strength, consistency, and scalability of cell therapies. This may improve clinical outcomes and make manufacturing easier as the field expands.